JeffreyMCraneMDFACP 1988

Oncology • Raleigh, NC

Hematologic Oncology

Staff Physician; UNC Rex Division of Hematology-Medical Oncology

Join to view full profile

Dr. Crane is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Crane's full profile

Already have an account?

Office
4420 Lake Boone Trl
Suite 200
Raleigh, NC 27607
Phone+1 919-784-6818

Fax+1 919-784-6826
Is this information wrong?

Summary

Retired

Education & Training

National Capital ConsortiumFellowship, Hematology and Medical Oncology, 1981 - 1984
National Capital ConsortiumResidency, Internal Medicine, 1979 - 1981
National Capital ConsortiumInternship, Internal Medicine, 1977 - 1978
University of Florida College of MedicineClass of 1977
University of Florida; Undergraduate StudiesBS, Zoology, Graduated with Honors, 1969 - 1973

Certifications & Licensure

NC State Medical License 2021 - 2025
MD State Medical License 1977 - 1990
SC State Medical License 1984 - 1987
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Lifetime Achievement Award: 2017 UNC Rex Medical Staff, 2017
Top Physician 2005-2015
NC Hospice and Home Health Leadership Excellence Award 2015
Regional Top Doctor Castle Connolly, 2005-2015
Retired USN, CDR, Medical Corps US Navy, 1979-1989
Fellow of the American College of Physicians (FACP) American College of Physicians, 1986
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

Single Arm on the Tolerability of Weekly Nab-paclitaxel Start of enrollment: 2013 Jun 25
Completed
Phase 2
Improving Survivorship Care Through Enhanced Communication and Coordination: Pilot Study Start of enrollment: 2013 Dec 01
Completed
Not Applicable

Publications & Presentations

PubMed

12 citations
Nab-paclitaxel in older patients with non–small cell lung cancer who have developed disease progression after platinum-based doublet chemotherapy
Jared Weiss, Nathan A. Pennell, Allison M. Deal, Daniel Morgensztern, Daniel S. Bradford, Jeffrey Crane, Howard Jack West, Carrie B. Lee, Chad V. Pecot, James P. Steve...> ;Cancer. 2020 Mar 1
22 citations
Using Survivorship Care Plans to Enhance Communication and Cancer Care Coordination: Results of a Pilot Study.
Deborah K. Mayer, Allison M. Deal, Jeffrey M. Crane, Ronald C. Chen, Gary Asher, Laura C. Hanson, Stephanie B. Wheeler, Adrian Gerstel, Melissa A. Green, Sarah A. Birk...> ;Oncology Nursing Forum. 2016 Sep 1
63 citations
A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancer
Young E. Whang, Andrew J. Armstrong, W. Kimryn Rathmell, Paul A. Godley, William Y. Kim, Raj S. Pruthi, Eric Wallen, Jeffrey M. Crane, Dominic T. Moore, Gayle Grigson,...> ;Urologic Oncology. 2013 Jan 1
15 citations
Phase I study of concurrent weekly docetaxel, high‐dose intensity‐modulated radiation therapy (IMRT) and androgen‐deprivation therapy (ADT) for high‐risk prostate cancer
Ronald C. Chen, Julian G. Rosenman, Leroy G. Hoffman, W.M. Chiu, Andrew Z. Wang, Raj S. Pruthi, Eric Wallen, Jeffrey M. Crane, William Y. Kim, W. Kimryn Rathmell, Paul...> ;BJU International. 2012 Dec 1
32 citations
A Randomized Phase II Trial of First-Line Treatment with Gemcitabine, Erlotinib, or Gemcitabine and Erlotinib in Elderly Patients (Age ≥70 Years) with Stage IIIB/IV No...
Thomas E. Stinchcombe, Amy H. Peterman, Carrie B. Lee, Dominic T. Moore, Jennifer L. Beaumont, Daniel S. Bradford, Kamal Bakri, Mark Taylor, Jeffrey M. Crane, Garry Sc...> ;Journal of Thoracic Oncology. 2011 Sep 1
145 citations
Neoadjuvant Clinical Trial With Sorafenib for Patients With Stage II or Higher Renal Cell Carcinoma
C. Lance Cowey, Chirag Amin, Raj S. Pruthi, Eric Wallen, Matthew E. Nielsen, Gayle Grigson, Cathy Watkins, Keith V. Nance, Jeffrey M. Crane, Mark Jalkut, Dominic Moore...> ;Journal of Clinical Oncology. 2010 Mar 20
Combination of bortezomib with a FLT3 inhibitor potentiates inhibition of proliferation and apoptosis of AML in vitro.
Cheng PC, Crane J, Hunter T> ;J. Clin. Oncol.. 2009-05-20
A phase II trial of lapatinib in hormone refractory prostate cancer.
Whang YE, Moore CN, Armstrong AJ, Rathmell WK, Godley PA, Crane JM, Grigson GI, Morris K, Watkins CP, George DJ> ;J. Clin. Oncol.. 2008-05-20
47 citations
Results of therapeutic cranial irradiation in small cell lung cancer.
James Carmichael, Jeffrey M. Crane, Paul A. Bunn, Eli Glatstein, Daniel C. Ihde> ;International Journal of Radiation Oncology, Biology, Physics. 1988 Mar 1
A comparison of computed tomography and radionuclide scanning for detection of brain metastases in small cell lung cancer.
Crane JM, Nelson MJ, Ihde DC, Makuch RW, Glatstein E, Zabell A, Johnston-Early A, Bates HR, Saini N, Cohen MH> ;J. Clin. Oncol.. 1984-09-01
Join now to see all

Committees

Hematology MED Oncology representative, BC/BS of NC Professional and Technical Review Board 1999 - 2015
Am Soc of Clin Oncol representative, AMA; Medical Accreditation and Quality Improvement 1998 - 2002
Chairman, Executive Committee of Rex Healthcare 1998 - 1999
Hematology, Medical Oncology Representative, State of NC Medicare Advisory Panel 1997 - 2001
President, RexHealthcare Medical Staff 1997 - 1998
Chairman, Rex Department of Internal Medicine 1995 - 1997
President, North Carolina Oncology Society 1994 - 1996
State of NC representative, Am Soc of Clin Oncol; Clinical Practice Committee 1992 - 2004
Secretary and Treasurer, Rex Healthcare Executive Committee 1991 - 1993